Clinical Trial: NCT05842044
NSAID Use After Robotic Partial Nephrectomy
Status:
ACTIVE NOT RECRUITINGPhase:
Phase 2| Lead Sponsor: | University of Miami |
| Information Provided By: | University of Miami |
| Last Update Posted: | 2026-10-23 |
Study Overview
Brief Summary
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Official Title
NSAID Use After Robotic Partial Nephrectomy (No-PAIN): a Randomized, Controlled Trial
Conditions
Kidney Cancer, Renal Cancer, Renal Neoplasm
Intervention / Treatment
- Drug: Ketorolac
- Drug: Acetaminophen
- Drug: Oxycodone
- Drug: Hydromorphone
- Drug: Ibuprofen
Other Study ID Numbers
- 20220783
Start Date (Actual)
2023-09-15
Primary Completion Date (Actual)
2026-10-09
Study Completion Date (Estimated)
2026-12-31
Enrollment (Actual)
137
Study Type
Interventional
Phase
Phase 2
| Lead Sponsor: | University of Miami |
| Information Provided By: | University of Miami |
| Last Update Posted: | 2026-10-23 |
Study Overview
Brief Summary
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Official Title
NSAID Use After Robotic Partial Nephrectomy (No-PAIN): a Randomized, Controlled Trial
Conditions
Kidney Cancer, Renal Cancer, Renal Neoplasm
Intervention / Treatment
- Drug: Ketorolac
- Drug: Acetaminophen
- Drug: Oxycodone
- Drug: Hydromorphone
- Drug: Ibuprofen
Other Study ID Numbers
- 20220783
Start Date (Actual)
2023-09-15
Primary Completion Date (Actual)
2026-10-09
Study Completion Date (Estimated)
2026-12-31
Enrollment (Actual)
137
Study Type
Interventional
Phase
Phase 2